Martin H. Voss

22.8k citations
219 papers · 6.1k indexed · 2 hit papers · h-index 40
Topics
Renal cell carcinoma treatment (173 papers)Renal and related cancers (76 papers)Cancer Genomics and Diagnostics (73 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
United StatesCanadaSpain

In The Last Decade

Martin H. Voss

206 papers receiving 6.1k citations

Hit Papers

Safety and Efficacy of Nivolumab in Combination With Ipil...201720262020202320172019100200300

Peers

Martin H. Voss
Comparison fields: 5 of 102
  • Pulmonary and Respiratory Medicine 4.0k
  • Molecular Biology 3.1k
  • Oncology 2.6k
  • Cancer Research 2.0k
  • Surgery 906
Replace Laura S. Wood with:
Laura S. Wood United States
Frede Donskov Denmark
Michael Siebels Germany
Manuel Cobo Spain
В. А. Горбунова Russia
Talia Golan Israel
Ihor Vynnychenko Ukraine
Naoyuki Nogami Japan
Saby George United States
Alexa B. Schrock United States
Martin H. Voss relative to Laura S. Wood United States Laura S. Wood's profile →
Citations per field
00.5×
Laura S. Wood · 1×
Citations per year

Countries citing papers authored by Martin H. Voss

Since Specialization
Citations

This map shows the geographic impact of Martin H. Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin H. Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin H. Voss more than expected).

Fields of papers citing papers by Martin H. Voss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin H. Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin H. Voss. The network helps show where Martin H. Voss may publish in the future.

Co-authorship network of co-authors of Martin H. Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Martin H. Voss. A scholar is included among the top collaborators of Martin H. Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin H. Voss. Martin H. Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 15
3 3
4 1
5 7
6 20
7 105
8 28
9 39
10 37
11 16
12 27
13 102
14 156
15 32
16 19
17
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Studybreakdown →
348
18 21
19 156
20 267

About Martin H. Voss

Martin H. Voss is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 219 papers that have together received 6.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (173 papers), Renal and related cancers (76 papers) and Cancer Genomics and Diagnostics (73 papers). The work is most often cited by research in Cancer Research (2.0k citations), Pulmonary and Respiratory Medicine (4.0k citations) and Oncology (2.6k citations). Martin H. Voss has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Robert J. Motzer, A. Ari Hakimi, Ritesh R. Kotecha, James J. Hsieh, Brian I. Rini, David F. McDermott, Ying‐Bei Chen, Lynda Vuong, Paul Russo and Hans J. Hammers. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026